Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Dec;9(6):456-458.
doi: 10.1212/CPJ.0000000000000621.

EBV-positive primary CNS lymphoma restricted to the conus medullaris in an immunocompetent host

Affiliations
Case Reports

EBV-positive primary CNS lymphoma restricted to the conus medullaris in an immunocompetent host

Reinier Alvarez et al. Neurol Clin Pract. 2019 Dec.
No abstract available

PubMed Disclaimer

Figures

Figure
Figure. MRI
Serial MRI of an Epstein–Barr virus (EBV)-positive primary CNS lymphoma (PCNSL) isolated to the conus medullaris: (A) T2 and (B) T1 post contrast images at initial presentation; (C) T1 post contrast image after surgical resection; (D) T2 image at 1 month after surgery, (E) after completion of chemotherapy, (F) and at 8 months after diagnosis and 4 months after completion of radiotherapy.

Similar articles

References

    1. Flanagan EP, O'Neill BP, Porter AB, Lanzino G, Haberman TM, Keegan BM. Primary intramedullary spinal cord lymphoma. Neurology 2011;77:784–791. - PubMed
    1. Cugati G, Singh M, Symss NP, Pande A, Vasudevan MC, Ramamurthi R. Primary spinal intradural extramedullary lymphoma causing cauda equina syndrome. J Craniovertebr Junction Spine 2012;3:58–61. - PMC - PubMed
    1. Guzey FK, Hitay Y, Isler C, et al. . Primary spinal intramedullary lymphoma: a case report and review of the literature. JSM Neurosurg Spine 2015;3:1049.
    1. Sugita Y, Terasaki M, Niino D, et al. . Epstein-Barr virus-associated primary central nervous system lymphomas in immunocompetent elderly patients: analysis for latent membrane protein-1 oncogene deletion and EBNA-2 strain typing. J Neurooncol 2010;100:271–279. - PubMed
    1. Ferreri AJM, Cwynarski K, Pulczynski E, et al. . Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol 2016;3:e217–e227. - PubMed

Publication types